Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.

Clinical trial NCT06784778 · RECRUITING

Trial details

NCT number: NCT06784778
Sponsor: Pamgene International B.V.
Status: RECRUITING
Study type: OBSERVATIONAL

Melanoma Metastatic Melanoma, Skin Melanoma Stage III or IV Melanoma Advanced

Start date: 2024-07-12
Primary completion: 2026-07-01
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.